Decent Value Stocks. Analyze the stocks with a good fundamental valuation, while still showing decent profitability, health and growth.
Taking everything into account, HALO scores 8 out of 10 in our fundamental rating. HALO was compared to 568 industry peers in the Biotechnology industry. HALO has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. HALO is evaluated to be cheap and growing strongly. This does not happen too often! These ratings would make HALO suitable for value and growth and quality investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 21.52% | ||
ROE | 122.06% | ||
ROIC | 23% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 54.32% | ||
PM (TTM) | 43.74% | ||
GM | 84.3% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.14 | ||
Debt/FCF | 3.21 | ||
Altman-Z | 4.71 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 7.8 | ||
Quick Ratio | 6.78 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 13.76 | ||
Fwd PE | 11.03 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 15.35 | ||
EV/EBITDA | 12.04 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |